• Health & Medicine

Almost 90,000 cancer cases caught by screening over last five years

New data analysis from our Cancer Intelligence team has shown that around 89,800 cancer cases have been detected by the three national screening programmes in England in the last five years New data analysis from our Cancer Intelligence team has shown that around 89,800 cancer cases have been detected by the three national screening programmes in England in the last five years

19 December 2024

• Health & Medicine

Bowel cancer rates rising in younger adults around the world

Rising rates of early-onset bowel cancer are a “global phenomenon” and some of the steepest increases are happening in England, according to a major new paper we helped fund. Rising rates of early-onset bowel cancer are a “global phenomenon” and some of the steepest increases are happening in England, according to a major new paper we helped fund.

11 December 2024

• Science & Technology

World-first urine test for lung cancer picks out 'zombie' cells

With our funding, scientists in Cambridge have created a urine test that can detect some of the first signs of lung cancer. With our funding, scientists in Cambridge have created a urine test that can detect some of the first signs of lung cancer.

6 December 2024

• Policy & Insight

Bringing our stories to Westminster – how our Campaigns Ambassadors are championing a smokefree UK

Last week more than 75 of our Campaigns Ambassadors gathered for Parliament Day to show their support for the Tobacco and Vapes Bill. Last week more than 75 of our Campaigns Ambassadors gathered for Parliament Day to show their support for the Tobacco and Vapes Bill.

3 December 2024

• Charity News

Beating cancer for everyone: our refreshed EDI strategy

We're launching our updated Equality, Diversity and Inclusion (EDI) strategy, outlining our renewed ambitions for the next five years. It will play a vital role in helping us achieve our vision of a world where everybody lives longer, better lives, free from the fear of cancer. We're launching our updated Equality, Diversity and Inclusion (EDI) strategy, outlining our renewed ambitions for the next five years. It will play a vital role in helping us achieve our vision of a world where everybody lives longer, better lives, free from the fear of cancer.

20 November 2024

• Charity News

£4m funding renewal for lung cancer research in Manchester and London

The Lung Cancer Centre of Excellence (LCCE) in Manchester and London will continue their groundbreaking research with up to £4m of funding support from ScottishPower.  The Lung Cancer Centre of Excellence (LCCE) in Manchester and London will continue their groundbreaking research with up to £4m of funding support from ScottishPower. 

20 November 2024

• Health & Medicine

100 lives saved from lung cancer every day

Almost 668,000 lives have been saved from lung cancer in the UK since the 1970s, according to our latest analysis. We're working to save more. Almost 668,000 lives have been saved from lung cancer in the UK since the 1970s, according to our latest analysis. We're working to save more.

14 November 2024

• Health & Medicine

NHS England offers an improved stop-smoking pill to help people quit

Varenicline has been shown to work as well as vapes and better than nicotine patches. It could prevent 9,500 deaths in the next five years. Varenicline has been shown to work as well as vapes and better than nicotine patches. It could prevent 9,500 deaths in the next five years.

12 November 2024

• Science & Technology

Could a chemical found in red grapes prevent bowel cancer?

Scientists funded by Cancer Research UK are finding out if an ingredient commonly found in red grapes could help prevent bowel cancer. Scientists funded by Cancer Research UK are finding out if an ingredient commonly found in red grapes could help prevent bowel cancer.

11 November 2024

• Science & Technology
• Health & Medicine

NICE recommends elranatamab for adults with a rare form of blood cancer

The National Institute for Health and Care Excellence (NICE) has recommended the use of elranatamab for adults with multiple myeloma, a cancer that forms in a type of white blood cell called a plasma cell. The National Institute for Health and Care Excellence (NICE) has recommended the use of elranatamab for adults with multiple myeloma, a cancer that forms in a type of white blood cell called a plasma cell.

1 November 2024

• Health & Medicine
• Policy & Insight

Around 350 young adults start smoking every day in the UK

New research that we funded has revealed that more than 127,000 18–25-year-olds start smoking tobacco regularly each year in the UK – that's around 350 per day. New research that we funded has revealed that more than 127,000 18–25-year-olds start smoking tobacco regularly each year in the UK – that's around 350 per day.

25 October 2024

• Science & Technology
• Charity News

£3m for world-first trial to revolutionise brain cancer treatment

A pioneering UK-wide trial, the 5G trial, has been awarded over £3m, by Cancer Research UK and the Minderoo Foundation, to test new treatments for people living with brain cancer.   A pioneering UK-wide trial, the 5G trial, has been awarded over £3m, by Cancer Research UK and the Minderoo Foundation, to test new treatments for people living with brain cancer.  

23 October 2024